Viewing nowSolcon Tablets (Polycarbophil Calcium)
Calcium Polycarbophil 625mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.

MFDS item code 201508551 · Approved 2015.12.31 · Insurance code 662503330
Improvement of chronic constipation and diarrhea (Irritable Bowel Syndrome, etc.) as an adjunct therapy
This medication is used as an adjunctive treatment for symptoms of constipation and diarrhea associated with chronic constipation, nonspecific diarrhea, and irritable bowel syndrome.
This medication should be taken orally with at least 250 mL of water or liquid. Administer 1,250 mg of polycarbophil calcium as a single dose 1 to 4 times a day. The recommended initial dosage for adults is between 1,250 mg and 2,500 mg per day, with a potential increase up to 5,000 mg per day. This medication produces results within 12 to 72 hours. Do not take it immediately before bedtime; allow at least 1 hour for digestion.
This medication should be taken orally with at least 250 mL of water or liquid. Children aged 6 to 12 years: Administer 625 mg of polycarbophil calcium 1 to 3 times a day. Children under 6 years should
This medication should not be used in certain patients. It should not be taken by individuals who are allergic to this medicine or any of its ingredients. Patients with unexplained rectal bleeding should also not take this medication. Patients with severe dehydration or those with conditions that make swallowing difficult should avoid this medication. Additionally, patients at risk of reflux, such as those who must remain in a supine position, should exercise caution. Patients with weakened colonic or bowel function, those with acute abdominal diseases, and those with intestinal obstruction or strictures should refrain from taking this medication. Patients with hypercalcemia or kidney stones may experience worsened symptoms and should not be administered this medicine. Patients with severe renal failure should also avoid this medication, and those with severe abdominal pain, nausea, or vomiting symptoms should take caution. Patients who need to limit calcium intake, those taking active vitamin D preparations, and those using cardiac glycosides should use this medication with caution. Patients with low gastric acid secretion or those who have undergone gastric resection, as well as patients on dialysis or with mild renal failure, should be careful when taking this medication. Allergic reactions such as rash or itching may occur while taking this medication, so if any unusual symptoms appear, it should be discontinued immediately. Gastrointestinal symptoms such as nausea, vomiting, abdominal pain, diarrhea, and constipation may also occur. Liver function test results may show elevation, and serious side effects such as intestinal obstruction or hypercalcemia have been reported rarely. This medication should be taken with water, as taking it without sufficient fluid may pose a choking hazard. If symptoms such as chest pain, difficulty swallowing, or shortness of breath occur after taking this medication, consult a doctor or pharmacist immediately. This medication is used to relieve symptoms, and if symptoms do not improve after taking it for more than 7 days, consult a doctor. During long-term use, patients should be monitored for adverse reactions closely. This medication may affect the absorption of other drugs when taken in conjunction with them, so it's advised to space out the intake of other medications by at least 2 hours. Particular caution should be taken when using it with certain antibiotics, active vitamin D preparations, calcium supplements, and cardiac glycosides due to the risk of side effects. Women who are pregnant should only take this medication if its safety is clearly established and only when deemed necessary under a doctor’s guidance. The safety for children has not been fully confirmed, so caution is warranted in their use. Elderly patients may have decreased kidney function and a higher risk of hypercalcemia, thus requiring dosage adjustments. This medication should be stored out of reach of children and kept at room temperature with low humidity. Store it in the original container, and avoid transferring it to another container as it may degrade quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering and should ideally be kept at a temperature between 1°C and 30°C. Storing it this way helps maintain the efficacy of the medication.
White oblong film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCalcium Polycarbophil 625mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Genupharm Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Heeon Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.